Diclofenac Sodium Micronized: Out of specification in the affected lot.
Dernière mise à jour
Summary
Produit
Diclofenac Sodium Micronized
Problème
Health products - Product quality
Ce qu’il faut faire
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Diclofenac Sodium Micronized |
Diclofenac Sodium Micronized |
N/A |
Powder |
N/A |
F601-20E29P1O |
Problème
The Loss on Drying is out of specification in the affected lot.
Ce que vous devriez faire
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Contexte
Depth of recall: Healthcare Establishments
Details
Original published date: 2023-03-21
Type d’avis ou de rappel
Health product recall
Catégorie
Health product - Drugs
Entreprises
AX Pharmaceutical Corp.
100 Tesma Way, Unit 8, Concord
ON L4K 0J9
Published by
Health Canada
Audience
General public
Healthcare
Industry
Classe de rappel
Type III
Identification number
RA-73363